As of Friday, January 23, Coherus Oncology, Inc.’s CHRS share price has surged by 21.70%, which has investors questioning if ...
A team from Würzburg has fundamentally changed our understanding of platelet biology. The researchers demonstrate that the ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
1 The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark 2 Autralian Institute for Bioengineering and Nanotechnology, The University of ...
ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and ...
Korea’s Celltrion is continuing to think bigger than biosmilars, this time securing the option to use TriOar’s antibody platform in a deal potentially worth more than $350 million. Under today’s ...
BACKGROUND Acanthamoeba is a free-living amoeba widely distributed, responsible for keratitis and granulomatous amoebic encephalitis. The presence of virulence factors in its excretion/secretion ...
A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published in Nature ...
The development of effective cancer vaccines relies on the ability to generate a strong and specific humoral immune response against tumor-associated antigens. The Tn antigen, a truncated O-glycan ...
The global Phospho-specific Antibodies Market is on a dynamic growth trajectory, poised to expand from USD 29.3 billion in 2025 to USD 87.1 billion by 2035, reflecting an impressive CAGR of 11.5% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results